Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
The combination provides a dual-mechanism research tool whose effects can in principle exceed those of either component alone
The Achieve-3 trial, funded by Eli Lilly, studied more than 1,500 adults with type 2 diabetes from 131 medical research centres and hospitals in Argentina, China, Japan, Mexico and the US
These innovations will significantly advance precision medicine and personalized treatment, playing a pivotal role in combating cancer, neurodegenerative diseases, and infectious diseases
The efficacy of PT-141 is still under investigation for the specific needs of premenopausal women
Observed Side Effects (From Clinical Trials) In the Lancet 2021 Phase 2 trial (n=706), at the highest 4.5 mg/week dose, 88% of participants reported at least one side effect and 63% reported a GI-specific event
US$ 21.29
US$ 28.35
US$ 23.11
US$ 24.11
US$ 24.98
US$ 21.44
US$ 20.43
US$ 28.38
US$ 26.13
